Efficiency and Productivity to Deliver Quality Patient Care
CBio builds analytical equipment to ensure cell and viral vector gene therapy actually works as expected.
​
Our proprietary platform, cellPhoresis®, uses novel separation science techniques, machine vision, and edge computing.
cellPhoresis® can expose hidden differences in otherwise considered homogenous populations.
Pilot Study
Identification of Neural Stem and Progenitor Cell Subpopulations using DC Insulator-based Dielectrophoresis
Yameng Liu, Alan Jiang, Estelle Kim, Clarissa Ro, Tayloria Adams, Lisa A. Flanegan, Thomas J. Taylor, and Mark A. Hayes
1.
cellPhoresis® tracks a unique electro-biophysical signature to measure and separate cells non-destructively (label-free)
A stable cell line was used to baseline the ability for cellPhoresis® to identify differences in mammalian cell population. As expected, very little difference identified
